The Natural History of Untreated Chlamydia trachomatis Infection in the Interval Between Screening and Returning for Treatment

Background: Studies of the natural history of genital chlamydial infections in humans are sparse and have had study design limitations. An improved understanding of chlamydial natural history may influence recommendations for elements of control efforts such as chlamydia screening frequency or time parameters for partner notification. Methods: Addressing limitations of prior studies in part, we are prospectively studying chlamydial natural history in sexually transmitted diseases clinic patients in the interval between screening and returning for treatment of positive chlamydial tests. Results of repeat chlamydial testing and clinical outcomes and their associated predictors are being evaluated. Results: In the initial 129 subjects, 89% were female, 88% were black, median age was 21 years, and the median interval between screening and treatment was 13 days. Based on nucleic acid amplification testing at treatment, spontaneous resolution of chlamydia occurred in 18%. Resolution was somewhat more common in subjects with longer intervals between screening and treatment. Persisting infections more often progressed to develop clinical signs at the time of treatment (e.g., urethritis or cervicitis). Two women and one man developed chlamydial complications between screening and treatment. Conclusions: Our findings demonstrate that although spontaneous resolution of chlamydia is common, many persons with persisting chlamydia progress to develop signs of infection and some develop complications.

[1]  S. Franceschi,et al.  The natural course of Chlamydia trachomatis infection in asymptomatic Colombian women: a 5-year follow-up study. , 2005, The Journal of infectious diseases.

[2]  S. Berman,et al.  Time to Treatment for Women With Chlamydial or Gonococcal Infections: A Comparative Evaluation of Sexually Transmitted Disease Clinics in 3 US Cities , 2005, Sexually transmitted diseases.

[3]  H. Caldwell,et al.  Polymorphisms in the Chlamydia trachomatis Cytotoxin Locus Associated with Ocular and Genital Isolates , 2004, Infection and Immunity.

[4]  S. Goldie,et al.  Screening for Chlamydia trachomatis in Women 15 to 29 Years of Age: A Cost-Effectiveness Analysis , 2004, Annals of Internal Medicine.

[5]  J. Paavonen,et al.  The accuracy and efficacy of screening tests for Chlamydia trachomatis: a systematic review. , 2002, Journal of medical microbiology.

[6]  S. Morré,et al.  The natural course of asymptomatic Chlamydia trachomatis infections: 45% clearance and no development of clinical PID after one-year follow-up , 2002, International journal of STD & AIDS.

[7]  Robert E. Johnson,et al.  Screening tests to detect Chlamydia trachomatis and Neisseria gonorrhoeae infections -- 2002 , 2002 .

[8]  J. Douglas,et al.  Persistence of Chlamydia trachomatis Infection Detected by Polymerase Chain Reaction in Untreated Patients , 2002, Sexually transmitted diseases.

[9]  C. Black,et al.  Typing of Chlamydia trachomatis strains from urine samples by amplification and sequencing the major outer membrane protein gene (omp1) , 2001, Sexually transmitted infections.

[10]  J. Schwebke,et al.  Patterns of Chlamydia trachomatis testing and follow-up at a University Hospital Medical Center. , 1999, Sexually transmitted diseases.

[11]  E. Hook,et al.  Spontaneous Clearance of Chlamydia trachomatis Infection in Untreated Patients , 1997, Sexually transmitted diseases.

[12]  Helen H. Lee,et al.  Evaluation of ligase chain reaction for use with urine for identification of Neisseria gonorrhoeae in females attending a sexually transmitted disease clinic , 1995, Journal of clinical microbiology.

[13]  T. Quinn,et al.  Use of cell culture and a rapid diagnostic assay for Chlamydia trachomatis screening. , 1994, JAMA.